{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T19:48:56Z","timestamp":1648756136824},"reference-count":90,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1053\/j.semtcvs.2007.06.003","type":"journal-article","created":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T20:32:41Z","timestamp":1191270761000},"page":"142-150","source":"Crossref","is-referenced-by-count":0,"title":["Medical Therapy for Chronic Obstructive Pulmonary Disease in 2007"],"prefix":"10.1053","volume":"19","author":[{"given":"Edward P.","family":"Ingenito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1053\/j.semtcvs.2007.06.003_bib1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.amjmed.2006.08.007","article-title":"Clinical course of chronic obstructive pulmonary disease: review of therapeutic interventions","volume":"119","author":"Anzueto","year":"2006","journal-title":"Am J Med"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/15412550600651552","article-title":"Case definitions for chronic obstructive pulmonary disease","volume":"3","author":"Hnizdo","year":"2006","journal-title":"COPD"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib3","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1164\/rccm.200508-1344OC","article-title":"Lung function decline and outcomes in an adult population","volume":"173","author":"Mannino","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib4","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0091-6749(93)90078-T","article-title":"Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease","volume":"92","author":"Lacoste","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0954-6111(96)90202-4","article-title":"Different cytokine patterns in bronchial biopsies in asthma and chronic bronchitis","volume":"90","author":"Mueller","year":"1996","journal-title":"Respir Med"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib6","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1164\/ajrccm.160.supplement_1.5","article-title":"Inflammation and repair processes in chronic obstructive pulmonary disease","volume":"160","author":"Rennard","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"suppl","key":"10.1053\/j.semtcvs.2007.06.003_bib7","doi-asserted-by":"crossref","first-page":"151S","DOI":"10.1378\/chest.121.5_suppl.151S","article-title":"Neutrophils and the pathogenesis of COPD","volume":"121","author":"Stockley","year":"2002","journal-title":"Chest"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib8","first-page":"607","article-title":"Cytokines in the airway mucosa of subjects with asthma induced by toluene diisocyanate","volume":"151","author":"Maestrelli","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib9","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1164\/ajrccm.152.6.8520757","article-title":"Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage","volume":"152","author":"Maestrelli","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib10","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1164\/rccm.2308002","article-title":"Neutrophil chemokines in severe exacerbations of chronic obstructive pulmonary disease: fatal chemo-attraction?","volume":"168","author":"Saetta","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib11","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1164\/ajrccm.150.6.7952628","article-title":"Airway eosinophilia in chronic bronchitis during exacerbations","volume":"150","author":"Saetta","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib12","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1164\/ajrccm.157.3.9709027","article-title":"CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease","volume":"157","author":"Saetta","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib13","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1164\/ajrccm.160.supplement_1.11","article-title":"Airway epithelial cells, cytokines, and pollutants","volume":"160","author":"Mills","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib14","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1034\/j.1399-3003.1999.14a27.x","article-title":"Increased MCP-1 and MIP-1beta in bronchoalveolar lavage fluid of chronic bronchitics","volume":"14","author":"Capelli","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib15","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1164\/ajrccm.156.2.9609066","article-title":"Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis","volume":"156","author":"Vignola","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib16","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1164\/ajrccm.158.6.9803053","article-title":"Transforming growth factor beta1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease","volume":"158","author":"de Boer","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib17","first-page":"241","article-title":"The release of elastase, myeloperoxidase, and lysozyme from human alveolar macrophages","volume":"126","author":"Cohen","year":"1982","journal-title":"Am Rev Respir Dis"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib18","first-page":"25","article-title":"Reduction of the elastase inhibitory capacity of alpha 1-antitrypsin by peroxides in cigarette smoke: an analysis of brands and filters","volume":"126","author":"Cohen","year":"1982","journal-title":"Am Rev Respir Dis"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib19","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1164\/ajrccm\/150.6_Pt_2.S160","article-title":"Elastolytic metalloproteinases produced by human mononuclear phagocytes","volume":"150","author":"Shapiro","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib20","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1182\/blood.V94.7.2487.419k07_2487_2496","article-title":"Presence of proteinase 3 in secretory vesicles: evidence of a novel, highly mobilizable intracellular pool distinct from azurophil granules","volume":"94","author":"Witko-Sarsat","year":"1999","journal-title":"Blood"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib21","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1165\/ajrcmb.20.4.3371","article-title":"Proteinase 3, a potent secretagogue in airways, is present in cystic fibrosis sputum","volume":"20","author":"Witko-Sarsat","year":"1999","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib22","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1681\/ASN.V1061224","article-title":"A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis","volume":"10","author":"Witko-Sarsat","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib23","first-page":"277","article-title":"Clinical practice guidelines for chronic obstructive pulmonary disease: a review and comparison of current resources","volume":"51","author":"Pierson","year":"2006","journal-title":"Respir Care"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1081\/COPD-120030163","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary updated 2003","volume":"1","author":"Fabbri","year":"2004","journal-title":"COPD"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib25","first-page":"798","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary","volume":"46","author":"Pauwels","year":"2001","journal-title":"Respir Care"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib26","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1378\/chest.130.5.1334","article-title":"Feasibility of retinoids for the treatment of emphysema study","volume":"130","author":"Roth","year":"2006","journal-title":"Chest"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib27","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1513\/pats.200505-047SR","article-title":"Combination therapy for chronic obstructive pulmonary disease: clinical aspects","volume":"2","author":"Donohue","year":"2005","journal-title":"Proc Am Thorac Soc"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib28","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1378\/chest.105.5.1411","article-title":"In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone","volume":"105","year":"1994","journal-title":"Chest"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib29","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1378\/chest.107.2.401","article-title":"Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide alone","volume":"107","author":"Ikeda","year":"1995","journal-title":"Chest"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib30","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1001\/jama.290.17.2301","article-title":"Contemporary management of chronic obstructive pulmonary disease: scientific review","volume":"290","author":"Sin","year":"2003","journal-title":"JAMA"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib31","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1136\/thx.54.12.1083","article-title":"Acute effect of pretreatment with single conventional dose of salmeterol on dose-response curve to oxitropium bromide in chronic obstructive pulmonary disease","volume":"54","author":"Cazzola","year":"1999","journal-title":"Thorax"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib32","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.rmed.2004.05.003","article-title":"The functional impact of adding salmeterol and tiotropium in patients with stable COPD","volume":"98","author":"Cazzola","year":"2004","journal-title":"Respir Med"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib33","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.rmed.2004.10.004","article-title":"Bronchodilator response to formoterol after regular tiotropium or to tiotropium after regular formoterol in COPD patients","volume":"99","author":"Cazzola","year":"2005","journal-title":"Respir Med"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.rmed.2004.10.009","article-title":"Efficacy of theophylline in people with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"99","author":"Ram","year":"2005","journal-title":"Respir Med"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib35","first-page":"871","article-title":"Responses to large doses of salbutamol and theophylline in patients with chronic obstructive pulmonary disease","volume":"132","author":"Filuk","year":"1985","journal-title":"Am Rev Respir Dis"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib36","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/thx.53.4.269","article-title":"Effects of theophylline and ipratropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease","volume":"53","author":"Tsukino","year":"1998","journal-title":"Thorax"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib37","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1378\/chest.119.6.1661","article-title":"Salmeterol plus theophylline combination therapy in the treatment of COPD","volume":"119","author":"ZuWallack","year":"2001","journal-title":"Chest"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib38","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0002-9440(10)65704-5","article-title":"Smoke extract stimulates lung epithelial cells to release neutrophil and monocyte chemotactic activity","volume":"153","author":"Masubuchi","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib39","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1513\/pats.200504-035SR","article-title":"Glucocorticoid pathways in chronic obstructive pulmonary disease therapy","volume":"2","author":"Adcock","year":"2005","journal-title":"Proc Am Thorac Soc"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib40","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/15412550500346683","article-title":"Histone deacetylation: an important mechanism in inflammatory lung diseases","volume":"2","author":"Adcock","year":"2005","journal-title":"COPD"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib41","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1183\/09031936.04.00121404","article-title":"Impact of preventing exacerbations on deterioration of health status in COPD","volume":"23","author":"Spencer","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib42","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1164\/ajrccm.153.6.8665061","article-title":"Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease","volume":"153","author":"Decramer","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib43","first-page":"56","article-title":"Severe chronic airflow obstruction: can corticosteroids slow down progression?","volume":"67","author":"Postma","year":"1985","journal-title":"Eur J Respir Dis"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib44","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1056\/NEJM199906243402503","article-title":"Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking","volume":"340","author":"Pauwels","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib45","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(98)10019-3","article-title":"Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial","volume":"353","author":"Vestbo","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib46","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1136\/bmj.320.7245.1297","article-title":"Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial","volume":"320","author":"Burge","year":"2000","journal-title":"BMJ"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib47","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0140-6736(03)12459-2","article-title":"Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial","volume":"361","author":"Calverley","year":"2003","journal-title":"Lancet"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib48","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1378\/chest.124.3.834","article-title":"The efficacy and safety of fluticasone propionate (250 microg)\/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD","volume":"124","author":"Hanania","year":"2003","journal-title":"Chest"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003794","article-title":"Combined corticosteroid and long acting beta-agonist in one inhaler for chronic obstructive pulmonary disease","volume":"3","author":"Nannini","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib50","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000096023","article-title":"Combination therapy with the single inhaler salmeterol\/fluticasone propionate versus increased doses of inhaled corticosteroids in patients with asthma","volume":"74","author":"Li","year":"2007","journal-title":"Respiration"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib51","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/15412550701341111","article-title":"Survival among COPD patients using fluticasone\/salmeterol in combination versus other inhaled steroids and bronchodilators alone","volume":"4","author":"Mapel","year":"2007","journal-title":"COPD"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib52","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.rmed.2006.10.025","article-title":"Post hoc analysis and claims of superiority in the EXCEL trial","volume":"101","author":"Naya","year":"2007","journal-title":"Respir Med"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib53","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1164\/ajrccm.157.2.9708012","article-title":"Phosphodiesterase isozymes: molecular targets for novel antiasthma agents","volume":"157","author":"Torphy","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib54","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1517\/13543784.10.7.1361","article-title":"Cilomilast: a second generation phosphodiesterase 4 inhibitor for asthma and chronic obstructive pulmonary disease","volume":"10","author":"Giembycz","year":"2001","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib55","unstructured":"Pulmonary-Allergy drug products advisory committee, Center for Drug Evaluation and Research, FDA, Department of Health and Human Services, SB 207499 (Cilomilast), GlaxoSmithKline. New Drugs Application (21-573), 2005"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib56","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/01926230490431493","article-title":"The toxicity of SCH 351591, a novel phosphodiesterase-4 inhibitor, in Cynomolgus monkeys","volume":"32","author":"Losco","year":"2004","journal-title":"Toxicol Pathol"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib57","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1164\/ajrccm.159.5.ats2-99","volume":"159","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib58","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1378\/chest.112.5.1363","article-title":"Pulmonary Rehabilitation: joint ACCP\/AACVPR evidence based guidelines. ACCP\/ACCVPR pulmonary rehabilitation guidelines panel, American College of Chest Physicians, American Association of Cardiovascular and Pulmonary Rehabilitation","volume":"112","year":"1997","journal-title":"Chest"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib59","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/ajrccm.160.4.9901014","article-title":"Exercise rehabilitation and chronic obstructive pulmonary disease stage","volume":"160","author":"Berry","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib60","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1183\/09031936.03.00059503","article-title":"Maintenance of inspiratory muscle training in COPD patients: one year follow-up","volume":"23","author":"Weiner","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib61","first-page":"30","article-title":"A simple and easy home-based pulmonary rehabilitation programme for patients with chronic lung diseases","volume":"63","author":"Na","year":"2005","journal-title":"Monaldi Arch Chest Dis"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib62","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1183\/09031936.94.07020269","article-title":"Quality of life in patients with chronic obstructive pulmonary disease improves after rehabilitation at home","volume":"7","author":"Wijkstra","year":"1994","journal-title":"Eur Respir J"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib63","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1440-1843.2006.00791.x","article-title":"Maintaining exercise capacity and quality of life following pulmonary rehabilitation","volume":"11","author":"Cockram","year":"2006","journal-title":"Respirology"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib64","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1155\/2005\/606378","article-title":"A Canadian, multicentre, randomized clinical trial of home-based pulmonary rehabilitation in chronic obstructive pulmonary disease: rationale and methods","volume":"12","author":"Maltais","year":"2005","journal-title":"Can Respir J"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib65","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1164\/rccm.200508-1211ST","article-title":"American Thoracic Society\/European Respiratory Society statement on pulmonary rehabilitation","volume":"173","author":"Nici","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl A","key":"10.1053\/j.semtcvs.2007.06.003_bib66","doi-asserted-by":"crossref","first-page":"11A","DOI":"10.1155\/2003\/567598","article-title":"Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease\u20132003","volume":"10","author":"O\u2019Donnell","year":"2003","journal-title":"Can Respir J"},{"issue":"Suppl B","key":"10.1053\/j.semtcvs.2007.06.003_bib67","doi-asserted-by":"crossref","first-page":"7B","DOI":"10.1155\/2004\/946769","article-title":"State of the Art Compendium: Canadian Thoracic Society recommendations for the management of chronic obstructive pulmonary disease","volume":"11","author":"O\u2019Donnell","year":"2004","journal-title":"Can Respir J"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib68","doi-asserted-by":"crossref","first-page":"391","DOI":"10.7326\/0003-4819-93-3-391","article-title":"Continuous or nocturnal oxygen therapy in chronic hypoxemic obstructive lung disease: a clinical trial","volume":"93","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib69","first-page":"681","article-title":"Report of the Medical Research Council Working Party","volume":"1","year":"1981","journal-title":"Lancet"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib70","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1046\/j.1445-5994.2001.00103.x","article-title":"Survival on long-term oxygen therapy in chronic airflow limitation: from evidence to outcomes in the routine clinical setting","volume":"31","author":"Crockett","year":"2001","journal-title":"Intern Med J"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib71","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1053\/rmed.2001.1064","article-title":"A review of long-term oxygen therapy for chronic obstructive pulmonary disease","volume":"95","author":"Crockett","year":"2001","journal-title":"Respir Med"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib72","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1479972306070506","article-title":"Long term oxygen therapy adherence and COPD: what we don\u2019t know","volume":"3","author":"Cullen","year":"2006","journal-title":"Chronic Respir Dis"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib73","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.200702-308OC","article-title":"Effect of oxygen on health quality of life in COPD patients with transient exertional hypoxemia","author":"Nonoyama","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib74","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005372.pub2","article-title":"Oxygen therapy during exercise training in chronic obstructive pulmonary disease","volume":"2","author":"Nonoyama","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib75","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1183\/09031936.06.00098805","article-title":"Short-burst oxygen therapy for COPD patients: a 6-month randomised, controlled study","volume":"27","author":"Eaton","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib76","doi-asserted-by":"crossref","DOI":"10.1136\/thx.2006.063636","article-title":"Effect of short burst oxygen therapy after activities of daily living in the home in chronic obstructive pulmonary disease","author":"Quantrill","year":"2007","journal-title":"Thorax"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib77","first-page":"178","article-title":"Cognitive functioning in patients with chronic obstructive pulmonary disease and mild hypoxemia compared with patients with mild Alzheimer disease and normal controls","volume":"12","author":"Kozora","year":"1999","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib78","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1136\/bmj.1.6077.1645","article-title":"The natural history of chronic airflow obstruction","volume":"1","author":"Fletcher","year":"1977","journal-title":"Br Med J"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib79","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJM200007273430402","article-title":"Effect of lung-volume-reduction surgery in patients with severe emphysema","volume":"343","author":"Geddes","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib80","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1539-6924.1995.tb00330.x","article-title":"Five-hundred life-saving interventions and their cost-effectiveness","volume":"15","author":"Tengs","year":"1995","journal-title":"Risk Anal"},{"issue":"suppl 5","key":"10.1053\/j.semtcvs.2007.06.003_bib81","first-page":"S1","article-title":"Guidance for commissioners on the cost effectiveness of smoking cessation interventions","volume":"53","author":"Parrott","year":"1998","journal-title":"Thorax"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib82","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/bmj.321.7257.355","article-title":"Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library","volume":"321","author":"Lancaster","year":"2000","journal-title":"BMJ"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib83","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000214","article-title":"Individual behavioural counselling for smoking cessation","volume":"2","author":"Lancaster","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib84","article-title":"Self-help interventions for smoking cessation","volume":"2","author":"Lancaster","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib85","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1001\/jama.259.19.2883","article-title":"Attributes of successful smoking cessation interventions in medical practice","volume":"259","author":"Kottke","year":"1988","journal-title":"JAMA"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib86","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199903043400903","article-title":"A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation","volume":"340","author":"Jorenby","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib87","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/00005082-200611000-00004","article-title":"Smoking cessation efficacy and safety of varenicline, an alpha4beta2 nicotinic receptor partial agonist","volume":"21","author":"Tonstad","year":"2006","journal-title":"J Cardiovasc Nurs"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib88","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1185\/030079907X182185","article-title":"A double-blind study evaluating the long-term safety of varenicline for smoking cessation","volume":"23","author":"Williams","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib89","first-page":"L305","article-title":"Postnatal treatment with retinoic acid increases the number of pulmonary alveoli in rats","volume":"270","author":"Massaro","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1053\/j.semtcvs.2007.06.003_bib90","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nm0697-675","article-title":"Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats","volume":"3","author":"Massaro","year":"1997","journal-title":"Nat Med"}],"container-title":["Seminars in Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043067907000901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043067907000901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T23:51:01Z","timestamp":1629849061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043067907000901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":90,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S1043067907000901"],"URL":"https:\/\/doi.org\/10.1053\/j.semtcvs.2007.06.003","relation":{},"ISSN":["1043-0679"],"issn-type":[{"value":"1043-0679","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}